Lates News

Citius Pharma (CTXR.US): The Q4 revenue report for 2025 showed a revenue of $0, same as the previous value, with an expected value of $5.756 million; earnings per share were -$0.11, compared to the previous value of -$1.72, and an expected value of -$0.24.